VRTX
Vertex Pharmaceuticals Incorporated · Healthcare
SVP, Controller Paul M Silva sold $1.4M of Vertex Pharmaceuticals Incorporated
Sold$1,442,301
$246.04Price
5,862Shares
−23%Stake
What VRTX did after the filing
- The stock from Wed, Feb 12 close, $242.21
- −7.3%
- S&P 500, same days
- −22.1%
Measured over 30 trading days, to the Mar 26 close.
Traded Tue, Feb 11. Filed Wed, Feb 12, 12:24 PM ET, during the session. Returns use the Feb 12 close and the Mar 26 close. Not investment advice.